Limbach Holdings (LMB) Tops Q3 EPS by 10c, Beats on Revenue; Offers FY24 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 58.11 +8.19 (16.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.92 | 52 Week High | $0.15 | |||
| Open | $56.21 | 52 Week Low | $0.15 | |||
| Day High | $58.99 | P/E | N/A | |||
| Day Low | $54.00 | EPS | $0.00 | |||
| Volume | 666,033 | |||||
